TMO (STOCKS)
Thermo Fisher Scientific, Inc.
$527.170000
-12.630000 (-2.34%)
Prev close: $539.800000
Company Information
- Exchange
- XNYS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Marc N. Casper
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $197,956.79M
- Employees
- 125,000
- P/E (TTM)
- 30.43
- P/B (TTM)
- 3.98
- Dividend Yield
- 31.86%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $43.74B |
| Benefits Costs and Expenses | $36.64B |
| Costs And Expenses | $36.23B |
| Operating Expenses | $36.23B |
| Selling, General, and Administrative Expenses | $8.58B |
| Research and Development | $1.42B |
| Other Operating Expenses | $26.23B |
| Operating Income/Loss | $7.51B |
| Income/Loss Before Equity Method Investments | $7.10B |
| Income/Loss From Continuing Operations After Tax | $6.55B |
| Income/Loss From Continuing Operations Before Tax | $7.10B |
| Income/Loss From Equity Method Investments | $24.00M |
| Income Tax Expense/Benefit | $544.00M |
| Income Tax Expense/Benefit, Deferred | -$930.00M |
| Net Income/Loss | $6.58B |
| Net Income/Loss Attributable To Noncontrolling Interest | $5.00M |
| Net Income/Loss Attributable To Parent | $6.57B |
| Net Income/Loss Attributable To Redeemable Noncontrolling Interest | -$20.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $6.57B |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $17.34 |
| Diluted Earnings Per Share | $17.31 |
| Basic Average Shares | 378,000,000 |
| Diluted Average Shares | 378,000,000 |
| Assets | $103.02B |
| Current Assets | $22.30B |
| Inventory | $5.75B |
| Other Current Assets | $16.55B |
| Noncurrent Assets | $80.73B |
| Fixed Assets | $10.18B |
| Intangible Assets | $16.24B |
| Other Non-current Assets | $54.31B |
| Liabilities | $52.00B |
| Current Liabilities | $14.89B |
| Accounts Payable | $3.12B |
| Wages | $1.88B |
| Other Current Liabilities | $9.88B |
| Noncurrent Liabilities | $37.11B |
| Long-term Debt | $35.48B |
| Other Non-current Liabilities | $1.62B |
| Redeemable Noncontrolling Interest | $129.00M |
| Equity | $51.02B |
| Equity Attributable To Noncontrolling Interest | $7.00M |
| Equity Attributable To Parent | $51.02B |
| Temporary Equity | $129.00M |
| Liabilities And Equity | $103.02B |
| Net Cash Flow From Operating Activities | $7.65B |
| Net Cash Flow From Operating Activities, Continuing | $7.65B |
| Net Cash Flow From Investing Activities | -$4.92B |
| Net Cash Flow From Investing Activities, Continuing | -$4.92B |
| Net Cash Flow From Financing Activities | -$5.39B |
| Net Cash Flow From Financing Activities, Continuing | -$5.39B |
| Net Cash Flow | -$2.66B |
| Net Cash Flow, Continuing | -$2.66B |
| Comprehensive Income/Loss | $6.25B |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $3.00M |
| Comprehensive Income/Loss Attributable To Parent | $6.25B |
| Other Comprehensive Income/Loss | -$325.00M |